Viatris Inc. (VTRS) financial statements: income statement, balance sheet and cash flow
Viatris Inc.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Viatris Inc. reported revenue of $14.3B (-3.0% year on year).
Income statement
Viatris Inc. income statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net sales
$14.3B
$14.7B
$15.4B
$16.2B
Other revenues
$49.5M
$46.5M
$38.5M
$44.6M
Total revenues
$14.3B
$14.7B
$15.4B
$16.3B
Cost of sales
$9.3B
$9.1B
$9.0B
$9.8B
Gross profit
$5.0B
$5.6B
$6.4B
$6.5B
Research and development
$965.9M
$808.7M
$805.2M
$662.2M
Acquired IPR&D
$48.3M
$28.3M
$105.5M
$36.4M
Selling, general and administrative
$3.8B
$4.4B
$4.7B
$4.2B
Impairment of goodwill
$2.9B
—
—
—
Litigation settlements and other contingencies, net
($68.5M)
$350.9M
$111.6M
$4.4M
Total operating expenses
$7.7B
$5.6B
$5.7B
$4.9B
Earnings (loss) from operations
($2.7B)
$10.1M
$766.2M
$1.6B
Interest expense
$471.3M
$550.0M
$573.1M
$592.4M
Other expense (income), net
$530.6M
$83.3M
($9.8M)
($1.8B)
Earnings (loss) before income taxes
($3.7B)
($623.2M)
$202.9M
$2.8B
Income tax (benefit) provision
($150.1M)
$11.0M
$148.2M
$734.6M
Net (loss) earnings
($3.5B)
($634.2M)
$54.7M
$2.1B
Basic (in USD per share)
-$3.00
-$0.53
$0.05
$1.71
Diluted (in USD per share)
-$3.00
-$0.53
$0.05
$1.71
Viatris Inc. income statement, quarters
Line item
Jun 30, 2026 · Q2
Mar 31, 2026 · Q1
Sep 30, 2025 · Q3
Jun 30, 2025 · Q2
Net sales
$3.7B
$3.5B
$3.7B
$3.6B
Other revenues
$10.9M
$7.3M
$12.4M
$13.1M
Total revenues
$3.8B
$3.5B
$3.8B
$3.6B
Cost of sales
$2.3B
$2.4B
$2.4B
$2.2B
Gross profit
$1.5B
$1.2B
$1.4B
$1.3B
Research and development
$248.3M
$248.6M
$250.4M
$218.8M
Acquired IPR&D
($5.8M)
$6.0M
$0
$0
Selling, general and administrative
$1.1B
$928.8M
$886.6M
$928.7M
Impairment of goodwill
$0
$0
$0
$0
Litigation settlements and other contingencies, net
$73.2M
$53.5M
$55.7M
($47.6M)
Total operating expenses
$1.5B
$1.2B
$1.2B
$1.1B
Earnings (loss) from operations
$6.3M
($79.7M)
$178.8M
$233.0M
Interest expense
$120.7M
$120.1M
$119.6M
$116.6M
Other (income) expense, net
($50.4M)
$47.5M
$67.1M
$333.5M
Loss before income taxes
($64.0M)
($247.3M)
($7.9M)
($217.1M)
Income tax provision (benefit)
$54.8M
($423.7M)
$120.3M
($212.5M)
Net (loss) earnings
($118.8M)
$176.4M
($128.2M)
($4.6M)
Basic (in USD per share)
-$0.10
$0.15
-$0.11
$0.00
Diluted (in USD per share)
-$0.10
$0.15
-$0.11
$0.00
Basic (in shares)
1.2B
1.2B
1.2B
1.2B
Diluted (in shares)
1.2B
1.2B
1.2B
1.2B
Balance sheet
Viatris Inc. balance sheet, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Cash and cash equivalents
$1.3B
$734.8M
$991.9M
$1.3B
Accounts receivable, net
$3.0B
$3.2B
$3.7B
$3.8B
Inventories
$4.0B
$3.9B
$3.5B
$3.5B
Prepaid expenses and other current assets
$1.4B
$1.7B
$2.0B
$1.8B
Total current assets
$9.8B
$9.5B
$13.0B
$10.6B
Property, plant and equipment, net
$2.6B
$2.7B
$2.8B
$3.0B
Intangible assets, net
$15.1B
$17.1B
$19.2B
$22.6B
Goodwill
$6.8B
$9.1B
$9.9B
$10.4B
Deferred income tax benefit
$1.1B
$753.0M
$692.9M
$925.9M
Other assets
$1.9B
$2.4B
$2.2B
$2.4B
Total assets
$37.2B
$41.5B
$47.7B
$50.0B
Accounts payable
$1.8B
$1.9B
$1.9B
$1.8B
Income taxes payable
$124.0M
$192.7M
$226.8M
$279.6M
Current portion of long-term debt and other long-term obligations
$1.9B
$8.3M
$1.9B
$1.3B
Other current liabilities
$3.3B
$3.7B
$3.4B
$3.4B
Total current liabilities
$7.1B
$5.8B
$7.8B
$6.7B
Long-term debt
$12.5B
$14.0B
$16.2B
$18.0B
Deferred income tax liability
$892.0M
$1.1B
$1.7B
$2.4B
Other long-term obligations
$2.0B
$1.9B
$1.5B
$1.8B
Total liabilities
$22.5B
$22.9B
$27.2B
$28.9B
Common stock: $0.01 par value, 3,000,000,000 shares authorized; shares issued: 1,245,391,929 as of December 31, 2025 and 1,234,131,491 as of December 31, 2024
12.5M
12.3M
12.2M
12.1M
Additional paid-in capital
$18.8B
$18.9B
$18.8B
$18.6B
Retained (deficit) earnings
($388.3M)
$3.4B
$4.6B
$5.2B
Accumulated other comprehensive loss
($2.7B)
($3.2B)
($2.7B)
($2.8B)
Stockholders Equity Parent Before Treasury Stock
$15.7B
$19.1B
$20.7B
—
Less: Treasury stock - at cost
$1.0B
$504.3M
$251.8M
—
Total equity
$14.7B
$18.6B
$20.5B
$21.1B
Total liabilities and equity
$37.2B
$41.5B
$47.7B
$50.0B
Viatris Inc. balance sheet, quarters
Line item
Jun 30, 2026
Mar 31, 2026
Sep 30, 2025
Jun 30, 2025
Cash and cash equivalents
$886.5M
$1.8B
$975.3M
$566.4M
Accounts receivable, net
$3.1B
$3.1B
$3.4B
$3.3B
Inventories
$3.9B
$3.9B
$4.1B
$4.3B
Prepaid expenses and other current assets
$2.1B
$2.1B
$1.5B
$1.7B
Total current assets
$10.1B
$10.9B
$10.0B
$9.8B
Property, plant and equipment, net
$2.4B
$2.5B
$2.6B
$2.6B
Intangible assets, net
$13.7B
$14.5B
$15.7B
$16.3B
Goodwill
$6.7B
$6.7B
$6.7B
$6.7B
Deferred income tax benefit
$1.2B
$1.1B
$999.0M
$924.3M
Other assets
$1.1B
$1.1B
$1.9B
$2.0B
Total assets
$35.0B
$36.8B
$37.9B
$38.4B
Accounts payable
$1.7B
$1.7B
$1.8B
$1.8B
Income taxes payable
$0
$0
$0
$0
Current portion of long-term debt and other long-term obligations
$1.7B
$1.9B
$2.0B
$1.7B
Other current liabilities
$2.9B
$3.1B
$3.6B
$3.7B
Total current liabilities
$6.3B
$6.8B
$7.4B
$7.1B
Long-term debt
$11.6B
$12.4B
$12.5B
$12.8B
Deferred income tax liability
$802.8M
$870.6M
$1.0B
$1.1B
Other long-term obligations
$2.0B
$2.1B
$1.8B
$1.8B
Total liabilities
$20.8B
$22.2B
$22.7B
$22.8B
Common stock: $0.01 par value, 3,000,000,000 shares authorized; shares issued: 1,258,784,090 and 1,245,391,929 as of June 30, 2026 and December 31, 2025
12.6M
12.6M
12.5M
12.5M
Additional paid-in capital
$18.6B
$18.7B
$18.9B
$19.0B
Retained deficit
($330.7M)
($211.9M)
($48.2M)
$80.0M
Accumulated other comprehensive loss
($2.8B)
($2.8B)
($2.7B)
($2.7B)
Total Viatris Inc. equity, before treasury stock
$15.4B
$15.7B
$16.1B
$16.4B
Less: Treasury stock — at cost
$1.2B
$1.0B
$924.2M
$855.8M
Total equity
$14.3B
$14.7B
$15.2B
$15.6B
Total liabilities and equity
$35.0B
$36.8B
$37.9B
$38.4B
Cash flow statement
Viatris Inc. cash flow statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net (loss) earnings
($3.5B)
($634.2M)
$54.7M
$2.1B
Depreciation and amortization
$2.8B
$2.9B
$2.7B
$3.0B
Deferred income tax benefit
($476.5M)
($767.6M)
($387.1M)
($25.9M)
Litigation settlements and other contingencies, net
($40.2M)
$274.5M
$86.8M
($1.7M)
Loss on disposal of business
$101.0M
$399.5M
$239.9M
($1.8B)
Share-based compensation expense
$177.7M
$146.1M
$180.7M
$116.4M
Acquired IPR&D
$50.8M
$12.3M
—
—
Impairment of goodwill
$2.9B
—
—
—
Other non-cash items
$969.3M
$297.7M
$595.4M
$434.3M
Accounts receivable
$334.6M
$300.1M
$78.6M
($240.3M)
Inventories
($106.4M)
($723.4M)
($613.3M)
($259.5M)
Trade accounts payable
($168.0M)
$36.0M
$314.7M
$170.2M
Income taxes
($112.9M)
$219.3M
($76.7M)
$25.3M
Other operating assets and liabilities, net
($633.7M)
($150.6M)
($414.6M)
($618.3M)
Net cash provided by operating activities
$2.3B
$2.3B
$2.8B
$3.0B
Cash paid for acquisitions, net of cash acquired
$0
($350.0M)
($667.7M)
$0
Capital expenditures
($378.8M)
($326.0M)
($377.0M)
($406.0M)
Payments for product rights and other, net
($35.5M)
($20.8M)
($97.5M)
($37.0M)
Proceeds from sale of property, plant and equipment
$34.9M
$2.7M
$14.0M
$13.8M
Purchases of IPR&D
($50.8M)
($12.3M)
—
—
Proceeds from sale of assets and subsidiaries
$2.5M
$2.5B
$364.1M
$1.9B
Purchase of marketable securities
($23.9M)
($26.0M)
($26.3M)
($30.2M)
Proceeds from the sale of marketable securities
$23.9M
$26.0M
$26.3M
$29.9M
Net cash (used in) provided by investing activities
($427.7M)
$1.8B
($764.1M)
$1.5B
Proceeds from issuance of long-term debt
$0
$0
$300.0K
$1.9B
Payments of long-term debt
($100.0K)
($3.7B)
($1.3B)
($3.7B)
Payments of financing fees
($1.5M)
($4.8M)
($500.0K)
($1.9M)
Change in short-term borrowings, net
$200.0K
$0
$300.0K
($1.5B)
Purchase of ordinary shares
-500.5M
-250.0M
-250.0M
—
Taxes paid related to net share settlement of equity awards
($30.2M)
($53.3M)
($38.2M)
($17.3M)
Contingent consideration payments
($13.1M)
($31.5M)
($8.4M)
($18.9M)
Cash dividends paid
($561.2M)
($574.8M)
($575.6M)
($581.6M)
Non-contingent payments for product rights
$0
$0
($9.7M)
$0
Issuance of common stock
$2.6M
$2.5M
$3.1M
$3.3M
Other items, net
($190.1M)
$295.2M
($173.0M)
$18.6M
Net cash used in financing activities
($1.3B)
($4.3B)
($2.3B)
($3.9B)
Effect on cash of changes in exchange rates
$17.6M
($30.7M)
($2.5M)
($38.9M)
Net increase (decrease) in cash, cash equivalents and restricted cash
$611.9M
($257.5M)
($268.9M)
$556.3M
Cash, cash equivalents and restricted cash — beginning of period
$736.1M
$993.6M
$1.3B
$706.2M
Cash, cash equivalents and restricted cash — end of period
$1.3B
$736.1M
$993.6M
$1.3B
Interest
$492.6M
$561.1M
$611.6M
$642.5M
Viatris Inc. cash flow statement, quarters
Line item
Jun 30, 2026 · YTD
Mar 31, 2026 · Q1
Sep 30, 2025 · YTD
Jun 30, 2025 · YTD
Net (loss) earnings attributable to Viatris Inc. common shareholders
$57.6M
$176.4M
($3.2B)
($3.0B)
Depreciation and amortization
$1.3B
$676.1M
$2.0B
$1.3B
Share-based compensation expense
$86.9M
$48.2M
$128.3M
$92.3M
Deferred income tax benefit
($194.2M)
($69.7M)
($228.3M)
($91.1M)
Loss on disposal of business
$13.9M
$13.9M
$79.1M
$80.7M
Acquired IPR&D
$200.0K
$6.0M
$15.0M
$15.0M
Impairment of goodwill
$0
$0
$2.9B
$2.9B
Other non-cash items
$377.3M
$182.3M
$835.8M
$726.3M
Litigation settlements and other contingencies, net
$130.2M
$58.0M
($45.1M)
($97.0M)
Accounts receivable
($252.8M)
($126.3M)
$62.7M
$158.4M
Inventories
($222.5M)
($123.0M)
($122.2M)
($232.7M)
Accounts payable
$11.5M
$32.7M
($186.5M)
($189.7M)
Income taxes
($422.5M)
($463.4M)
($238.4M)
($366.6M)
Other operating assets and liabilities, net
($163.9M)
($22.9M)
($593.8M)
($573.6M)
Net cash provided by operating activities
$770.1M
$388.3M
$1.5B
$755.2M
Proceeds from the sale of investments
$400.0M
$400.0M
—
—
Capital expenditures
($92.7M)
($39.9M)
($182.3M)
($95.5M)
Purchase of marketable securities
($16.8M)
($7.5M)
($18.1M)
($10.9M)
Proceeds from the sale of marketable securities
$16.8M
$7.5M
$18.1M
$10.9M
Payments for product rights and other, net
($83.0M)
($82.0M)
($32.9M)
($20.0M)
Purchases of IPR&D
($8.3M)
($2.3M)
($15.0M)
($15.0M)
Proceeds from the sale of property, plant and equipment
$9.8M
$1.6M
$13.7M
$12.9M
Net cash provided by (used in) investing activities
$225.8M
$277.4M
($216.5M)
($117.6M)
Proceeds from issuance of long-term debt
$1.3B
—
—
—
Payments of long-term debt
($2.2B)
—
$0
$0
Purchase of common stock
($150.0M)
$0
($415.4M)
($350.4M)
Change in short-term borrowings, net
$0
$0
$1.7M
$1.4M
Taxes paid related to net share settlement of equity awards
($56.8M)
($56.5M)
($30.3M)
($29.5M)
Contingent consideration payments
($11.4M)
($7.9M)
($13.1M)
($13.1M)
Payments of financing fees
($3.0M)
—
($1.3M)
($1.0M)
Cash dividends paid
($279.4M)
($139.6M)
($423.0M)
($283.1M)
Issuance of common stock
$1.2M
$500.0K
$2.0M
$1.3M
Other items, net
($24.8M)
($300.0K)
($178.1M)
($155.0M)
Net cash used in financing activities
($1.4B)
($203.8M)
($1.1B)
($829.4M)
Effect on cash of changes in exchange rates
($7.5M)
($4.2M)
$41.3M
$23.5M
Net decrease in cash, cash equivalents and restricted cash
($458.0M)
$457.7M
$267.4M
($168.3M)
Cash, cash equivalents and restricted cash — beginning of period
$1.3B
$1.3B
$736.1M
$736.1M
Cash, cash equivalents and restricted cash — end of period